熱門詞: 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
美國,RPS,ReSearch Pharmaceutical Services,
RPS 為制藥、生物技術(shù)、醫(yī)療設(shè)備和診斷行業(yè)提供綜合性的全球 I-IV 期臨床開發(fā)解決方案。通過將該公司十分成熟的臨床研究運(yùn)營架構(gòu)與業(yè)界最大的資源引擎相結(jié)合,RPS 能夠?yàn)榭蛻籼峁V泛的外包解決方案。這些解決方案包括從全球嵌入式職能和跨職能項(xiàng)目到增強(qiáng)型全球綜合解決方案,由經(jīng)驗(yàn)豐富的項(xiàng)目團(tuán)隊(duì)提供創(chuàng)新、無縫、劃算且優(yōu)質(zhì)的服務(wù)。
RPS 擁有5000多名員工,其業(yè)務(wù)遍及全球逾64個(gè)國家。
Founded in 1998 by Daniel M. Perlman, RPS built an innovative new business model specifically to address the anticipated challenges facing the biopharmaceutical industry:
Tougher regulatory environment demanding increased QUALITY
Increasing COST pressures and need for enhanced EFFICIENCIES
Biopharmaceutical and Device and Diagnostic Industries desire to retain strategic CONTROL of core competencies
Increased GLOBALIZATION of clinical trials